UNSPSC 85502119: Supplement right subclavian artery with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right subclavian artery with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U33KZ

UNSPSC 85502119 Supplement right subclavian artery with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows no alignment between its clinical procedural name and the work actually being solicited by state and local governments under this classification. The recent opportunities block contains no solicitations for subclavian artery supplementation, vascular surgical procedures, or related implantable devices; instead, the tagged opportunities span occupational medical surveillance, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical benefit carve-out network management, temporary clinical staffing pools, and emergency medical services for youth in custody. None of these activities involve the specific vascular intervention the code nominally describes.

The mismatch suggests the code has been applied in a state or local procurement system as a misclassification artifact or catch-all placeholder rather than reflecting genuine buying activity in subclavian artery supplementation. Until opportunities specifically addressing vascular surgical devices, implant supply chains, or procedural support services for subclavian interventions appear in state and local procurement records, this code shows no actionable market signal for vendors in that specialty. The code warrants monitoring for reclassification or correction by issuing procurement offices, but current activity does not support business development pursuit under its stated scope.